PARPi also demonstrates profound immunomodulatory effects, promoting anti-tumor immune responses by upregulating cytotoxic immune cells such as CD8+ T-cells, B-cells, and NK cells, while decreasing the number of myeloid-derived suppressor cells [86,87]. This evidence concerns the gene CD8A and neoplasm.